Pharmaceutical company Evolus has expanded its UK distribution, with its toxin Nuceiva now being sold through Healthxchange and Medfx as well as Wigmore Medical.
The company says the choice to expand distribution came after increasing demand for Nuceiva to be more widely available across the UK. Healthxchange and Medfx customers can now order the toxin through their pharmacies.
Suse Alexander, general manager at Evolus UK, said, “We understand the importance of choice, and that’s why we are pleased to be expanding access to Nuceiva, our new botulinum toxin type A. Giving customers choice as we evolve the aesthetics market is in our DNA. Partnering with additional pharmacy suppliers will make it easier for customers to order through their preferred provider.”
